MCM
SIOX

Moore Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Moore Capital Management’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,000
Closed -$815K – 434
2015
Q2 		$815K Buy
+5,000
New +$847K 0.02% 380

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Moore Capital Management's SIOX Position: Q3 2015 in Review

Moore Capital Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2015, closing a stake of 5,000 shares — an estimated $815K sold.

Moore Capital Management first reported a position in SIOX in Q2 2015 and held it in 1 quarter. The position peaked at $815K in Q2 2015. 71 funds tracked by Wall St. Rank hold SIOX as of Q3 2015.

  • Moore Capital Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Moore Capital Management sold 5,000 Sio Gene Therapies Inc. Common Stock shares in Q3 2015, an estimated $815K.
  • Moore Capital Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • Moore Capital Management's Sio Gene Therapies Inc. Common Stock position peaked at $815K in Q2 2015.
  • 71 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2015.

Based on Moore Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.